Literature DB >> 24364522

Assessment of asymptomatic microscopic hematuria in adults.

Victoria J Sharp1, Kerri T Barnes1, Bradley A Erickson1.   

Abstract

Although routine screening for bladder cancer is not recommended, microscopic hematuria is often incidentally discovered by primary care physicians. The American Urological Association has published an updated guideline for the management of asymptomatic microscopic hematuria, which is defined as the presence of three or more red blood cells per high-power field visible in a properly collected urine specimen without evidence of infection. The most common causes of microscopic hematuria are urinary tract infection, benign prostatic hyperplasia, and urinary calculi. However, up to 5% of patients with asymptomatic microscopic hematuria are found to have a urinary tract malignancy. The risk of urologic malignancy is increased in men, persons older than 35 years, and persons with a history of smoking. Microscopic hematuria in the setting of urinary tract infection should resolve after appropriate antibiotic treatment; persistence of hematuria warrants a diagnostic workup. Dysmorphic red blood cells, cellular casts, proteinuria, elevated creatinine levels, or hypertension in the presence of microscopic hematuria should prompt concurrent nephrologic and urologic referral. The upper urinary tract is best evaluated with multiphasic computed tomography urography, which identifies hydronephrosis, urinary calculi, and renal and ureteral lesions. The lower urinary tract is best evaluated with cystoscopy for urethral stricture disease, benign prostatic hyperplasia, and bladder masses. Voided urine cytology is no longer recommended as part of the routine evaluation of asymptomatic microscopic hematuria, unless there are risk factors for malignancy.

Entities:  

Mesh:

Year:  2013        PMID: 24364522

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

1.  Microscopic hematuria and urothelial malignancy.

Authors:  Sim Sai Tin; Viroj Wiwanitkit
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

2.  Nutcracker Syndrome and Sickle Cell Trait: A Perfect Storm for Hematuria.

Authors:  Amier Ahmad; Samuel K McElwee; Ryan R Kraemer
Journal:  J Gen Intern Med       Date:  2017-02-16       Impact factor: 5.128

Review 3.  A practical approach to chronic kidney disease in primary care.

Authors:  Seng Wee Cheo; Qin Jian Low; Tzyy Huei Lim; Woh Wei Mak; Chow Alexander Kok Yip; Koh Wei Wong
Journal:  Malays Fam Physician       Date:  2022-03-02

4.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

5.  Low level of antibodies to the oral bacterium Tannerella forsythia predicts bladder cancers and Treponema denticola predicts colon and bladder cancers: A prospective cohort study.

Authors:  Lise Lund Håheim; Dag S Thelle; Kjersti S Rønningen; Ingar Olsen; Per E Schwarze
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

6.  Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases.

Authors:  Won Seok Yang
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

7.  Does non-visible haematuria require urgent assessment? A retrospective cohort study from a university teaching hospital.

Authors:  James Lucocq; Adnan Ali; William Harrison; Tarek Khalil; Gursunil Powar; Kamran Raza; Ghulam Nandwani
Journal:  World J Urol       Date:  2021-03-24       Impact factor: 4.226

8.  The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma.

Authors:  Jay D Raman; Laimonis Kavalieris; Badrinath Konety; Sima Porten; Siamak Daneshmand; Yair Lotan; Ronald Loo
Journal:  J Urol       Date:  2021-08-05       Impact factor: 7.450

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.